These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 18285700)
1. Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1. Huang XZ; Wang J; Huang C; Chen YY; Shi GY; Hu QS; Yi J Cancer Biol Ther; 2008 Mar; 7(3):468-75. PubMed ID: 18285700 [TBL] [Abstract][Full Text] [Related]
2. Emodin enhances sensitivity of gallbladder cancer cells to platinum drugs via glutathion depletion and MRP1 downregulation. Wang W; Sun YP; Huang XZ; He M; Chen YY; Shi GY; Li H; Yi J; Wang J Biochem Pharmacol; 2010 Apr; 79(8):1134-40. PubMed ID: 20005210 [TBL] [Abstract][Full Text] [Related]
3. Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation. Li X; Wang H; Wang J; Chen Y; Yin X; Shi G; Li H; Hu Z; Liang X BMC Cancer; 2016 Aug; 16():578. PubMed ID: 27485374 [TBL] [Abstract][Full Text] [Related]
4. Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance. Ding N; Zhang H; Su S; Ding Y; Yu X; Tang Y; Wang Q; Liu P Anticancer Agents Med Chem; 2018; 18(7):1054-1063. PubMed ID: 29256357 [TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids. Wartenberg M; Hoffmann E; Schwindt H; Grünheck F; Petros J; Arnold JR; Hescheler J; Sauer H FEBS Lett; 2005 Aug; 579(20):4541-4549. PubMed ID: 16083877 [TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
7. Exploration of effects of emodin in selected cancer cell lines: enhanced growth inhibition by ascorbic acid and regulation of LRP1 and AR under hypoxia-like conditions. Masaldan S; Iyer VV J Appl Toxicol; 2014 Jan; 34(1):95-104. PubMed ID: 23212659 [TBL] [Abstract][Full Text] [Related]
8. PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species. Warfel NA; Sainz AG; Song JH; Kraft AS Mol Cancer Ther; 2016 Jul; 15(7):1637-47. PubMed ID: 27196781 [TBL] [Abstract][Full Text] [Related]
9. Emodin has cytotoxic and protective effects in rat C6 glioma cells: roles of Mdr1a and nuclear factor kappaB in cell survival. Kuo TC; Yang JS; Lin MW; Hsu SC; Lin JJ; Lin HJ; Hsia TC; Liao CL; Yang MD; Fan MJ; Wood WG; Chung JG J Pharmacol Exp Ther; 2009 Sep; 330(3):736-44. PubMed ID: 19549930 [TBL] [Abstract][Full Text] [Related]
10. Emodin augments cisplatin cytotoxicity in platinum-resistant ovarian cancer cells via ROS-dependent MRP1 downregulation. Ma J; Yang J; Wang C; Zhang N; Dong Y; Wang C; Wang Y; Lin X Biomed Res Int; 2014; 2014():107671. PubMed ID: 25580427 [TBL] [Abstract][Full Text] [Related]
11. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Yang J; Li H; Chen YY; Wang XJ; Shi GY; Hu QS; Kang XL; Lu Y; Tang XM; Guo QS; Yi J Free Radic Biol Med; 2004 Dec; 37(12):2027-41. PubMed ID: 15544921 [TBL] [Abstract][Full Text] [Related]
12. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells. Lai JM; Chang JT; Wen CL; Hsu SL Eur J Pharmacol; 2009 Nov; 623(1-3):1-9. PubMed ID: 19744477 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342 [TBL] [Abstract][Full Text] [Related]
14. Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression. Wang W; Sun Y; Li X; Li H; Chen Y; Tian Y; Yi J; Wang J Oncol Rep; 2011 Nov; 26(5):1143-8. PubMed ID: 21769433 [TBL] [Abstract][Full Text] [Related]
15. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism. Ai Z; Lu Y; Qiu S; Fan Z Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746 [TBL] [Abstract][Full Text] [Related]
16. The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells. Sasabe E; Zhou X; Li D; Oku N; Yamamoto T; Osaki T Int J Cancer; 2007 Jan; 120(2):268-77. PubMed ID: 17066447 [TBL] [Abstract][Full Text] [Related]
17. [Hypoxia/reoxygenation and lipopolysaccharide induced nuclear factor-ΚB and hypoxia-inducible factor-1α signaling pathways in intestinal epithelial cell injury and the interventional effect of emodin]. Qi L; Yuan B; Fu Q Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jun; 26(6):409-14. PubMed ID: 24912640 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of HIF-1α by siRNA-expressing plasmid delivered by attenuated Salmonella enhances the antitumor effects of cisplatin on prostate cancer. Gu J; Li Y; Zeng J; Wang B; Ji K; Tang Y; Sun Q Sci Rep; 2017 Aug; 7(1):7546. PubMed ID: 28790395 [TBL] [Abstract][Full Text] [Related]
19. [Reversing effects of emodin on multidrug resistance in resistant HL-60/ADR cells]. Chen YY; Li J; Hu JD; Zheng J; Zheng ZH; Zhu LF; Chen XJ; Lin ZX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1413-22. PubMed ID: 24370022 [TBL] [Abstract][Full Text] [Related]
20. Alteration of subcellular redox equilibrium and the consequent oxidative modification of nuclear factor kappaB are critical for anticancer cytotoxicity by emodin, a reactive oxygen species-producing agent. Jing Y; Yang J; Wang Y; Li H; Chen Y; Hu Q; Shi G; Tang X; Yi J Free Radic Biol Med; 2006 Jun; 40(12):2183-97. PubMed ID: 16785032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]